MCL1 may not mediate chemoresistance

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The anti-apoptotic BCL2 family member MCL1 is frequently overexpressed in cancers and associated with treatment resistance.
• MCL1 has known mitochondrial functions and proposed nuclear roles in chemoresistance, cell cycle, and DNA repair.

Purpose of the Study:

• To investigate the proposed nuclear functions of MCL1 in chemoresistance.
• To determine if MCL1 translocates to the nucleus and influences chemoresistance during chemotherapy.

Main Methods:

• Utilized a newly validated monoclonal antibody against MCL1 in various cancer cell lines.
• Employed proximity biotinylation to identify nuclear MCL1 interactors.
• Assessed MCL1 localization and its impact on chemoresistance following drug exposure.

Main Results:

• No evidence was found that MCL1 enhances chemoresistance or accumulates in the nucleus post-drug treatment.
• Novel nuclear MCL1 interactors were identified, but previously reported DNA repair and cell cycle partners were not recovered.
• Data do not support a role for MCL1 in conferring chemoresistance through nuclear mechanisms.

Conclusions:

• The study challenges previous findings implicating nuclear MCL1 in chemoresistance.
• MCL1's nuclear translocation and interaction with DNA repair proteins during chemotherapy were not observed.
• Further research is required to elucidate the functional significance of nuclear MCL1.